Table Of Contents

1. Introduction 22
1.1. Objectives Of The Study 22
1.2. Market Definition 22
1.3. Overview Of Global Hla Typing Transplant Diagnostics Services Market 22
1.4. Currency And Pricing 23
1.5. Limitation 23
1.6. Markets Covered 24
2. Market Segmentation 26
2.1. Markets Covered 26
2.2. Geographic Scope 27
2.3. Years Considered For The Study 28
2.4. Currency And Pricing 28
2.5. Research Methodology 29
2.6. Primary Interviews With Key Opinion Leaders 32
2.7. Secondary Sources 33
2.8. Assumptions 33
3. Market Overview 34
3.1. Drivers 36
3.1.1. Technological Advancements In Hla Typing 36
3.1.2. Increasing Number Of Solid Organ And Stem Cell Transplantation Procedures 37
3.1.3. Increased Research Grants, Funds, And Public-Private Investments 37
?
3.2. Restraints 38
3.2.1. Weak Reimbursements For Organ Donation And Transplantation Procedures 38
3.2.2. Expensive Ngs And Pcr-Based Devices 38
3.3. Opportunities 39
3.3.1. Rising Healthcare Infrastructure In Emerging Nations 39
3.4. Challenges 40
3.4.1. Significant Gap Between Number Of Organs Donated And Organs Required Annually 40
3.4.2. Lack Of Trained Staff 41
4. Executive Summary 42
5. Premium Insights 45
6. Global Hla Typing Transplant Diagnostics Services Market, By Technology 48
6.1. Overview 49
6.2. Next-Generation Sequencing (Ngs) 51
6.3. Polymerase Chain Reaction (Pcr) 52
6.3.1. Pcr Ssop (Sequence-Specific Oligonucleotide) 53
6.3.2. Pcr Ssp (Sequence-Specific Primer) 53
6.3.3. Pcr-Sbt (Sequencing Based Typing) 54
7. Global Hla Typing Transplant Diagnostics Services Market, By End-User 55
7.1. Overview 56
7.2. Specialty Clinics 58
7.3. Hospitals 59
7.4. Transplant Centers 60
7.5. Academic Institutes 61
?
8. Global Hla Typing Transplant Diagnostics Services Market, By Geography 62
8.1. Overview 63
8.2. North America 70
8.2.1. U.S. 77
8.2.2. Canada 79
8.2.3. Mexico 81
8.3. Europe 83
8.3.1. Germany 91
8.3.2. France 93
8.3.3. U.K. 95
8.3.4. Italy 97
8.3.5. Spain 99
8.3.6. Switzerland 101
8.3.7. Netherlands 103
8.3.8. Belgium 105
8.3.9. Russia 107
8.3.10. Turkey 109
8.3.11. Rest Of Europe 111
8.4. Asia-Pacific 112
8.4.1. China 120
8.4.2. Japan 122
8.4.3. India 124
8.4.4. South Korea 126
8.4.5. Australia 128
8.4.6. Singapore 130
8.4.7. Thailand 132
8.4.8. Malaysia 134
8.4.9. Indonesia 136
8.4.10. Philippines 138
8.4.11. Rest Of Asia-Pacific 140
8.5. South America 141
8.5.1. Brazil 148
8.5.2. Rest Of South America 150
8.6. Middle East & Africa 151
8.6.1. Rest Of Middle East And Africa 158
8.6.2. South Africa 160
9. Global Hla Typing Transplant Diagnostics Services Market, Company Landscape 161
9.1. Company Share Analysis; Global 161
9.2. Company Share Analysis; North America 162
9.3. Company Share Analysis; Europe 163
9.4. Company Share Analysis; Asia Pacific 164
10. Company Profiles 165
10.1. Proimmune Ltd. 165
10.1.1. Company Overview 165
10.1.2. Proimmune Ltd.; Company Snapshot 165
10.1.3. Product Portfolio 166
10.1.4. Recent Developments 166
10.2. Creative Biolabs 167
10.2.1. Company Overview 167
10.2.2. Creative Biolabs; Company Snapshot 167
10.2.3. Product Portfolio 167
10.2.4. Recent Developments 167
10.3. Histogenetics Llc 168
10.3.1. Company Overview 168
10.3.2. Histogenetics Llc; Company Snapshot 168
10.3.3. Product Portfolio 168
10.3.4. Recent Developments 168
10.4. The Ucla Immunogenetics Center 169
10.4.1. Company Overview 169
10.4.2. The Ucla Immunogenetics Center; Company Snapshot 169
10.4.3. Product Portfolio 169
10.4.4. Recent Developments 169
10.5. Admera Health 170
10.5.1. Company Overview 170
10.5.2. Admera Health; Company Snapshot 170
10.5.3. Product Portfolio 171
10.5.4. Recent Developments 171
10.6. Quick Biology 172
10.6.1. Company Overview 172
10.6.2. Quick Biology; Company Snapshot 172
10.6.3. Product Portfolio 172
10.6.4. Recent Developments 172
10.7. New York Blood Center 173
10.7.1. Company Overview 173
10.7.2. New York Blood Center; Company Snapshot 173
10.7.3. Product Portfolio 173
10.7.4. Recent Developments 173
10.8. The Sequencing Center 174
10.8.1. Company Overview 174
10.8.2. The Sequencing Center; Company Snapshot 174
10.8.3. Product Portfolio 175
10.8.4. Recent Developments 175
?
10.9. Bloodcenter Of Wisconsin 176
10.9.1. Company Overview 176
10.9.2. Bloodcenter Of Wisconsin; Company Snapshot 176
10.9.3. Product Portfolio 176
10.9.4. Recent Developments 176
10.10. Laboratory Corporation Of America Holdings 177
10.10.1. Company Overview 177
10.10.2. Laboratory Corporation Of America Holdings; Revenue Analysis 177
10.10.3. Product Portfolio 178
10.10.4. Recent Developments 178
10.11. Thermo Fisher Scientific Inc. 179
10.11.1. Company Overview 179
10.11.2. Thermo Fisher Scientific Inc. ;Revenue Analysis 179
10.11.3. Product Portfolio 180
10.11.4. Recent Developments 180
11. Related Reports 181

?